Skip to content

Optimizing the Tobacco Cessation Clinical Decision Support Tool.

Using Rapid Cycle Randomized Controlled Trials to Study a Tobacco Cessation Best Practice Advisory.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03714191
Enrollment
54417
Registered
2018-10-22
Start date
2018-10-03
Completion date
2020-02-29
Last updated
2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use Cessation

Brief summary

The existing tobacco cessation best practice advisory (BPA) fires for providers (physicians, residents, fellows, midwives, nurse practitioners, physician assistants) during outpatient encounters when a patient is identified as a current tobacco user in the Social History section of their chart. The BPA was designed to help facilitate tobacco cessation interventions; it is part of the The Centers for Medicare & Medicaid Services (CMS) Quality Payment Program (QPP). The purpose of the project is to optimize this BPA utilization and improve patient outcomes by comparing multiple versions of the tobacco cessation BPA.

Interventions

OTHERPatient Outcomes

The intervention includes different versions of the BPA design and message.

OTHERBilling documentation

The intervention includes different versions of the BPA design and message.

OTHERRegulatory

The intervention includes different versions of the BPA design and message.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All providers of patients at NYU Langone Health (including NYU Winthrop) who are identified as currents smokers, as documented in the social history of their patient chart, and are eligible to receive the best practice advisory for tobacco cessation.

Exclusion criteria

* non smokers

Design outcomes

Primary

MeasureTime frame
Alert acceptance rate1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026